An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy
Silvia Mihaela Ilie, Julie Lecuelle, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire · 2026
Read An expression signature of 19 human endogenous retroviruses identifies immunogenic luminal breast cancers likely to respond to immunotherapy by Silvia Mihaela Ilie, Julie Lecuelle, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13314411.txt.
Description
Silvia Mihaela Ilie and colleagues find a viral fingerprint that may flag breast cancers ripe for immune therapy, in a study from 2026. Old retroviruses sit in our DNA, making up about 8 percent of the genome as stated in the report. When cancer cells wake them, the immune system can react as if a virus were present.
The team used public RNA data from The Cancer Genome Atlas for breast tumors and matched normal tissue, counting retrovirus activity with a tool called Telescope. They built a signature of 19 such viruses whose activity tied to signs of this viral mimicry inside tumors. Luminal breast cancers with high signature scores looked more immune-active and more likely to answer immune therapy. The marker could help pick patients for drugs that free the immune system.
Catalog record
| CREATOR | Silvia Mihaela Ilie, Julie Lecuelle, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49890 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |